Logo

What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective

M.C. Hochberg

CER1975
2001 Vol.19, N°6 ,Suppl.25 - PI 0015, PF 0022
11th International Congress on Systemic Lupus Erythematosus

Free to view (click on article PDF icon to read the article)

Rheumatology Article